Profile data is unavailable for this security.
About the company
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. The Company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
- Revenue in GBP (TTM)4.31bn
- Net income in GBP433.27m
- Incorporated1937
- Employees18.37k
- LocationSmith & Nephew PLCBuilding 5, Croxley Park, Hatters LaneWATFORD WD18 8YEUnited KingdomGBR
- Phone+44 207 401 7646
- Fax+44 207 930 3353
- Websitehttp://www.smith-nephew.com/
More ▼
Mergers & acquisitions
| Acquired company | SN.:LSE since announced | Transaction value |
|---|---|---|
| Engage Surgical | -7.37% | 135.00m |
Data delayed at least 20 minutes, as of Jul 01 2022 16:45 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elekta AB (publ) | 1.17bn | 92.56m | 2.14bn | 4.59k | 23.91 | 3.10 | 12.12 | 1.83 | 3.02 | 3.02 | 38.08 | 23.33 | 0.5688 | 3.78 | 2.77 | -- | 4.52 | 4.84 | 8.36 | 8.86 | 37.36 | 41.03 | 7.95 | 8.88 | 0.8948 | -- | 0.3898 | 58.41 | 5.70 | 6.33 | -7.97 | 55.98 | 12.71 | 19.14 |
| Oxford Nanopore Technologies PLC | 133.66m | -167.61m | 2.19bn | 803.00 | -- | 3.10 | -- | 16.39 | -0.2438 | -0.2438 | 0.1826 | 0.8569 | -- | -- | -- | 166,452.10 | -- | -- | -- | -- | 54.76 | -- | -125.40 | -- | 6.55 | -674.32 | 0.034 | -- | 17.39 | -- | -173.68 | -- | -- | -- |
| GN Store Nord A/S | 1.80bn | 126.43m | 4.12bn | 7.75k | 30.92 | 5.50 | 14.75 | 2.29 | 8.38 | 8.38 | 120.04 | 47.09 | 0.6925 | 3.31 | 5.37 | 2,147,759.00 | 5.04 | 9.04 | 7.16 | 12.20 | 53.08 | 58.31 | 7.28 | 11.12 | 0.5826 | 10.84 | 0.7163 | 33.63 | 17.29 | 12.77 | 40.26 | 10.09 | 14.20 | 6.15 |
| ConvaTec Group PLC | 1.69bn | 97.24m | 4.62bn | 10.03k | 46.87 | 3.23 | 17.04 | 2.74 | 0.048 | 0.048 | 0.8317 | 0.6956 | 0.5479 | 3.02 | 6.37 | 168,118.60 | 3.16 | 3.20 | 3.70 | 3.59 | 55.10 | 54.24 | 5.77 | 6.31 | 1.41 | 3.95 | 0.4585 | 95.56 | 7.60 | 3.84 | 4.53 | -- | 6.74 | -- |
| Getinge AB | 2.17bn | 229.48m | 4.91bn | 10.89k | 22.94 | 2.52 | 13.07 | 2.26 | 10.50 | 10.50 | 99.36 | 95.78 | 0.5995 | 2.67 | 6.46 | 2,522,416.00 | 6.40 | 3.34 | 7.94 | 4.45 | 50.08 | 48.06 | 10.67 | 5.78 | 1.39 | 37.71 | 0.1392 | 40.67 | -9.29 | 4.06 | -8.31 | 33.59 | -10.36 | 15.20 |
| Amplifon SpA | 1.73bn | 147.33m | 5.93bn | 12.59k | 40.16 | 6.97 | 17.37 | 3.43 | 0.7568 | 0.7312 | 8.84 | 4.36 | 0.581 | 22.24 | 11.44 | 159,130.90 | 4.96 | 4.61 | 6.52 | 6.12 | 24.61 | 55.81 | 8.54 | 7.24 | 0.6275 | 10.11 | 0.6221 | 29.10 | 29.59 | 11.45 | 64.67 | 20.12 | 12.65 | 30.01 |
| Demant A/S | 2.13bn | 291.23m | 7.26bn | 18.12k | 25.40 | 8.19 | -- | 3.41 | 10.71 | 10.71 | 78.31 | 33.22 | 0.786 | 2.11 | 5.87 | 1,015,014.00 | 10.81 | 8.89 | 17.80 | 14.48 | 75.13 | 75.23 | 13.75 | 11.63 | 0.5031 | 23.54 | 0.5869 | 0.00 | 27.29 | 8.94 | 124.17 | 11.49 | 11.83 | -- |
| Carl Zeiss Meditec AG | 1.50bn | 227.90m | 8.93bn | 3.75k | 39.16 | 5.96 | 63.46 | 5.97 | 2.96 | 2.96 | 19.39 | 19.43 | 0.7314 | 2.34 | 10.80 | 491,312.40 | 11.22 | 8.57 | 13.79 | 10.56 | 59.40 | 56.59 | 15.34 | 11.34 | 2.70 | 8.77 | 0.1062 | 36.15 | 23.31 | 8.64 | 93.06 | 19.16 | 18.81 | 16.47 |
| Smith & Nephew plc | 4.31bn | 433.27m | 10.10bn | 18.37k | 23.49 | 2.21 | 11.20 | 2.34 | 0.4931 | 0.4931 | 4.90 | 5.24 | 0.4753 | 0.873 | 4.35 | 234,612.40 | 4.78 | 6.69 | 5.79 | 8.08 | 70.40 | 72.54 | 10.05 | 12.34 | 1.21 | 11.75 | 0.3749 | 52.90 | 14.30 | 2.22 | 16.96 | -7.74 | 0.8033 | 5.28 |
| Koninklijke Philips NV | 14.87bn | 423.34m | 15.63bn | 78.55k | 38.05 | -- | 9.74 | 1.05 | 0.5304 | 3.41 | 19.19 | -- | -- | -- | -- | 220,593.70 | -- | 3.59 | -- | 5.01 | 41.70 | 45.57 | 2.86 | 5.64 | -- | 21.27 | -- | -- | -0.9068 | -0.3072 | -38.65 | -5.05 | 0.1845 | 1.63 |
| Straumann Holding AG | 1.74bn | 341.27m | 15.82bn | 9.05k | 46.48 | 12.27 | 36.53 | 9.08 | 2.48 | 2.48 | 12.67 | 9.40 | 0.733 | 2.07 | 5.99 | 223,316.00 | 14.48 | 12.91 | 17.50 | 15.62 | 76.17 | 75.16 | 19.75 | 18.08 | 2.27 | 8.32 | 0.3121 | 33.30 | 41.80 | 17.12 | 333.91 | 11.52 | 20.97 | 9.69 |
| Sonova Holding AG | 2.90bn | 559.19m | 16.85bn | 16.73k | 29.89 | 7.85 | 22.36 | 5.81 | 10.36 | 10.36 | 53.64 | 39.46 | 0.5843 | 2.52 | 7.37 | 201,033.90 | 11.53 | 10.50 | 15.24 | 13.55 | 73.23 | 71.80 | 19.73 | 17.47 | 0.8282 | 25.00 | 0.3384 | 33.65 | 29.29 | 7.02 | 14.20 | 12.58 | 1.65 | 13.85 |
| Coloplast A/S | 2.39bn | 550.00m | 18.97bn | 13.51k | 37.14 | 24.14 | 29.45 | 7.94 | 22.26 | 22.26 | 96.66 | 34.24 | 0.8174 | 2.50 | 6.10 | 1,618,950.00 | 18.83 | 32.35 | 50.53 | 54.61 | 68.75 | 67.95 | 23.03 | 23.37 | 0.2136 | 1,096.17 | 0.7435 | 87.95 | 4.76 | 5.76 | 14.96 | 8.95 | 24.82 | 7.07 |
Data as of Jul 01 2022. Currency figures normalised to Smith & Nephew PLC's reporting currency: UK Pound GBX
27.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wellington Management Co. LLPas of 31 Dec 2020 | 42.67m | 4.89% |
| BlackRock Investment Management (UK) Ltd.as of 31 Dec 2021 | 33.66m | 3.86% |
| The Vanguard Group, Inc.as of 01 Jun 2022 | 28.41m | 3.26% |
| BlackRock Fund Advisorsas of 12 Feb 2021 | 24.77m | 2.84% |
| Walter Scott & Partners Ltd.as of 01 Jun 2022 | 23.19m | 2.66% |
| Norges Bank Investment Managementas of 01 Jun 2022 | 18.20m | 2.09% |
| Rathbone Investment Management Ltd.as of 01 Jun 2022 | 16.77m | 1.92% |
| Legal & General Investment Management Ltd.as of 01 Jun 2022 | 16.72m | 1.92% |
| Fidelity Management & Research Co. LLCas of 01 Jun 2022 | 15.94m | 1.83% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 01 Jun 2022 | 15.57m | 1.79% |
More ▼
Data from 31 Dec 2021 - 31 Mar 2022Source: FactSet Research Systems Inc.
